Demis Hassabis Business Ventures
The first thread dates back to April, when a report surfaced claiming Demis Hassabis had quietly built a hedge fund operation inside DeepMind, with ambitions to challenge the quantitative trading legacy of Jim Simons and Renaissance Technologies. Google, the story goes, shut it down. Whether that reflects a principled decision about focus, a legal concern, or simply a founder being reined in by a parent company, we don't know — the details remain thin. Then, six weeks later, something more concrete arrived. Isomorphic Labs, the drug discovery spinout Hassabis founded in 2021 and still leads alongside his DeepMind role, announced a Series B round carrying $2.1 billion in new funding. That number is not speculative. It is the kind of figure that shows up in wire services and regulatory filings, and it changes the scale of what Isomorphic can attempt.
If confirmed in full, here is what this means. The hedge fund episode, however it ended, reveals something important about Hassabis: he is not content to be a research figurehead. He is drawn toward building, toward markets, toward the places where intelligence can be tested against hard reality. The Isomorphic raise reinforces that picture. Two billion dollars buys serious clinical pipeline development, top-tier computational biology talent, and the kind of independence from Google's balance sheet that turns a spinout into a genuine company. The strategic significance is considerable — if Isomorphic can demonstrate that AI-designed drugs actually work in humans, it validates a thesis that has been expensive to believe in for several years. And Hassabis sitting at the intersection of that effort, while also apparently eyeing financial markets, suggests a founder with an unusually broad appetite for domains where AI might be transformative.
Watch for formal documentation of the Isomorphic Series B — lead investors, terms, and any partnership announcements with pharmaceutical companies. And if any former DeepMind employees speak on the record about the hedge fund project, the picture of Hassabis's ambitions outside pure research will sharpen considerably.
<table> <tr><td> <a href="https://www.reddit.com/r/OpenAI/comments/1s9bjdz/openai_raises_122000000000/"> <img alt="OpenAI raises $122,000,000,000"
<!-- SC_OFF --><div class="md"><p><a
<table> <tr><td> <a href="https://www.reddit.com/r/singularity/comments/1vht8bp/google_shifts_ai_power_back_to_brin_as_deepminds/"> <img alt="Google shifts AI power back to Brin
<!-- SC_OFF --><div class="md"><p>Demis’ timeline on AGI has been shrinking and shrinking lately. I believe he would consistently say 5-10 years away the past year or 2. Then he
  submitted by   <a href="https://www.reddit.com/user/borowcy"> /u/borowcy </a> <br /> <span><a
<table> <tr><td> <a href="https://www.reddit.com/r/singularity/comments/1x7u2hn/vals_ai_moves_its_prediction_for_full_recursive/"> <img alt="Vals AI moves its prediction for full
Google's Demis Hassabis goes on the offensive reut.rs/4urqkVU
<table> <tr><td> <a href="https://www.reddit.com/r/singularity/comments/1s0ql5r/openai_to_double_workforce_as_business_push/"> <img alt="OpenAI to double workforce as business
NewsHive monitors these sources continuously. All signal titles above link to the original reporting.
Intelligence by NewsHive. Need help navigating what this means for your business? Contact GeekyBee →